NCT04794595 Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
| NCT ID | NCT04794595 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2020-12-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2020-12-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored. In this study, we need to explore the efficacy and the timing of application of CBP in children with sepsis or septic shock.
Eligibility Criteria
Inclusion Criteria: * Age of 29d to 18 years old; * Children diagnosed with sepsis requiring blood purification. Exclusion Criteria: * with a history of a duration of PICU stay \<24 h * active bleeding, including cerebral hemorrhage
Contact & Investigator
Lu guoing
PRINCIPAL INVESTIGATOR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT04794595 clinical trial?
This trial is open to participants of all sexes, aged 28 Days or older, up to 18 Years, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04794595 currently recruiting?
Yes, NCT04794595 is actively recruiting participants. Contact the research team at jiayundoctor@163.com for enrollment information.
Where is the NCT04794595 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04794595 clinical trial?
NCT04794595 is sponsored by Children's Hospital of Fudan University. The principal investigator is Lu guoing at Children's Hospital of Fudan University. The trial plans to enroll 90 participants.